Understanding stem cell immunogenicity in therapeutic applications

Understanding stem cell immunogenicity in therapeutic applications

Stem cells and their differentiated progeny offer great hope for treating disease by providing an unlimited source of cells for repairing or replacing damaged tissue. Initial studies suggested that, unlike 'normal' transplants, specific characteristics of stem cells enabled them to avoid i...

Descripció completa

Dades bibliogràfiques
Autors principals:	Wood, K, Issa, F, Hester, J
Format:	Journal article
Idioma:	English
Publicat:	Cell Press 2015

Ítems similars

Immunogenicity of embryonic stem cell-derived progenitors after transplantation.
per: English, K, et al.
Publicat: (2011)

Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.
per: Milward, K, et al.
Publicat: (2013)

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
per: Alzhrani, A, et al.
Publicat: (2020)

Revealing the Therapeutic Potential of Stem Cells in Burn Healing: A Deeper Understanding of the Therapeutic Mechanisms of Epidermal Stem Cells and Mesenchymal Stem Cells
per: Jianyu Lu, et al.
Publicat: (2024-01-01)

Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy
per: Durga Khandekar, et al.
Publicat: (2019-04-01)

Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model.
per: Issa, F, et al.
Publicat: (2012)

Understanding cancer stem cells and plasticity: Towards better therapeutics
per: Neerada Meenakshi Warrier, et al.
Publicat: (2023-06-01)

Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants.
per: Anabel S de la Garza-Rodea, et al.
Publicat: (2011-01-01)

Immunogenic cell death in cancer: concept and therapeutic implications
per: Lorenzo Galluzzi, et al.
Publicat: (2023-03-01)

Immunogenicity of CAR-T Cell Therapeutics: Evidence, Mechanism and Mitigation
per: Aalia N. Khan, et al.
Publicat: (2022-05-01)

Therapeutic implications of immunogenic cell death in human cancer
per: Fabio ePalombo, et al.
Publicat: (2014-01-01)

Regulatory T cells for tolerance
per: Kawai, K, et al.
Publicat: (2017)

Hematopoietic stem cells: Understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation
per: Amjad Ahmed Aljagthmi, et al.
Publicat: (2025-02-01)

Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells
per: Alix K. Berglund, et al.
Publicat: (2017-12-01)

Elimination of the immunogenicity of therapeutic antibodies.
per: Gilliland, L, et al.
Publicat: (1999)

Enhancing human regulatory T cells in vitro for cell therapy applications
per: Milward, K, et al.
Publicat: (2017)

Modulation of CD27/CD70 co-stimulatory pathway may allow for the generation of a more potent human regulatory T cell product for cell therapy
per: Arroyo Hornero, R, et al.
Publicat: (2017)

The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives
per: Xin Liu, et al.
Publicat: (2017-06-01)

Understanding menstrual blood-derived stromal/stem cells: Definition and properties. Are we rushing into their therapeutic applications?
per: Alicia Sanchez-Mata, et al.
Publicat: (2021-12-01)

Stem cells and cancer stem cells : therapeutic applications in disease and injury /
per: Hayat, M. A., 1940-
Publicat: (c201)

Editorial: Immunogenicity of Proteins Used as Therapeutics
per: Zuben E. Sauna, et al.
Publicat: (2020-10-01)

Tissue targeted regulatory T cell therapy prevents human skin allograft rejection in a humanised mouse model
per: Issa, F, et al.
Publicat: (2013)

Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses
per: Zaitsu, M, et al.
Publicat: (2017)

Stem cells : nuclear reprogramming and therapeutic applications /
per: Bock, Gregory, et al.
Publicat: (2005)

Immunogenicity of undifferentiated and differentiated allogeneic mouse mesenchymal stem cells
per: Blessing Mukonoweshuro, et al.
Publicat: (2014-04-01)

Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.
per: Ding, Y, et al.
Publicat: (2010)

Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells.
per: Pengfei Liu, et al.
Publicat: (2013-01-01)

Recent advances in our understanding of the allograft response
per: Hennessy, C, et al.
Publicat: (2021)

Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.
per: Tseng, S, et al.
Publicat: (2009)

Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicity
per: Michel Siegel, et al.
Publicat: (2024-08-01)

Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells.
per: Xiaoying Wang, et al.
Publicat: (2014-01-01)

Understanding the application of stem cell therapy in cardiovascular diseases
per: Sharma RK, et al.
Publicat: (2012-10-01)

Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
per: Jasmine Davda, et al.
Publicat: (2019-04-01)

Stem cells and cancer stem cells, volume 12 : therapeutic applications in disease and injury /
per: Hayat, M. A., 1940- , editor
Publicat: (2014)

Low Immunogenicity of Keratinocytes Derived from Human Embryonic Stem Cells
per: Jiayi Shen, et al.
Publicat: (2024-08-01)

Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells
per: Tobias Deuse, et al.
Publicat: (2011-06-01)

The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
per: Li Zhang, et al.
Publicat: (2015-01-01)

Molecular Imaging of Stem Cells: Tracking Survival, Biodistribution, Tumorigenicity, and Immunogenicity
per: Eugene Gu, Wen-Yi Chen, Jay Gu, Paul Burridge, Joseph C. Wu
Publicat: (2012-01-01)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients
per: Bottomley, M, et al.
Publicat: (2022)

Stem Cells Applications in Regenerative Medicine and Disease Therapeutics
per: Ranjeet Singh Mahla
Publicat: (2016-01-01)